>>> US Gapping down

Gapping down
In reaction to disappointing earnings/guidance
: CFMS -40%, APDN -15.1%, BIOC -13.6%, VJET -11.6%, JCP -9.7%, DDS -6.8%, ANY -5%, SYMC -3.4%, ARGS -2.7%, HMC -1.8%, TGB -1.1%, BITA -1.1%, WPRT -0.5%

M&A news: BUD -1.3% (Anheuser-Busch InBev and AmBev (ABEV) agree to exchange certain AmBev and SABMiller (SBMRY) businesses in Latin America)

Select oil/gas related names showing early weakness: MRO -2.2%, RDS.A -1.7%, TOT -1.7%, BP -1.2%, WLL -1.2%, CHK -1%

Other news: TTPH -23.9% (receives guidance from the FDA regarding the regulatory path for eravacycline; FDA advises that data from one additional positive phase 3 clinical trial will be required to support an NDA submission), ECC -10.3% (to commence 1.25 mln share public offering of common stock), KORS -2.4% (in sympathy with JWN earnings), ABB -2% (still checking), KSS -1.3% (in sympathy with JCP earnings), NFLX -0.8% (California Public Employees' Retirement System (CalPERS) and the New York City Pension Funds request shareowners vote for non-binding proposal to give shareowners effective access to the director nomination process)

Analyst comments: WDC -3.2% (downgraded to Underperform from Neutral at BofA/Merrill), MYL -1.6% (removed from Conviction Buy List at Goldman), LMT -1.2% (downgraded to Hold from Buy at Stifel), JNJ -0.5% (owngraded to Neutral from Buy at BTIG Research)